This NDC is on FDA's drug shortage list (posted Jul 26, 2023)

Reported reason: Demand increase for the drug

Product Information

METHYLPHENIDATE ER 54 MG TAB is a generic product labeled by Trigen Laboratories, LLC, priced at $0.8092 per EA under NDC 13811070910. Its NADAC has been published 466 times since Sep 20, 2017.

FDA first approved this application on Jul 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE ER 54 MG TAB

Methylphenidate hydrochloride
$0.8092per EA
DEA Schedule CII

Strength

54 mg/1

NDC

13811070910

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205327

FDA Approved

7/28/2017

TE Code

AB

On Market Since

8/14/2017

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER 54 MG TAB has been published 466 times since Sep 20, 2017, and over the history we have for it it has declined 90.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8092 per EA
All-time high$8.5288 (Apr 11, 2018)
All-time low$0.6051 (Feb 22, 2023)
52-week high$0.8562
52-week low$0.7632
Median price$1.0471
Average price$2.8550
Largest weekly change+71.1% (Nov 22, 2023)
Weeks tracked466
Tracking sinceSep 20, 2017

Price History

1W

-0.1%

1M

-0.1%

3M

-3.5%

6M

+6.0%

1Y

-5.5%

3Y

-14.9%

5Y

-44.7%

All

-90.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER 54 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 54 MG TAB, manufactured by Trigen Laboratories, LLC, is $0.8092 per EA (NDC 13811070910), effective Aug 19, 2026.

How has the price of METHYLPHENIDATE ER 54 MG TAB changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER 54 MG TAB has declined 90.4%. It has been tracked across 466 weekly CMS publications since Sep 20, 2017.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 54 MG TAB?

Since Sep 20, 2017, the NADAC for METHYLPHENIDATE ER 54 MG TAB has ranged from a low of $0.6051 (Feb 22, 2023) to a high of $8.5288 (Apr 11, 2018), with a median of $1.0471 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER 54 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE ER 54 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPHENIDATE ER 54 MG TAB?

METHYLPHENIDATE ER 54 MG TAB (NDC 13811070910) is labeled by Trigen Laboratories, LLC, and CMS classifies it as a generic product.

Is METHYLPHENIDATE ER 54 MG TAB in shortage?

Yes — NDC 13811070910 is currently listed in FDA's drug shortage database (posted Jul 26, 2023). Reported reason: Demand increase for the drug.